Common use of Warrant Amount; Term Clause in Contracts

Warrant Amount; Term. The Company hereby agrees to issue and sell to the Underwriter (and/or its designees) on the Closing Date a warrant for the purchase of a number of the Ordinary Shares equal to 5% of the number of the Firm Shares, issued in the Offering, pursuant to the form attached hereto as Exhibit A (the “Underwriter’s Warrant”), at an initial exercise price of $[●], which is equal to 120% of the public offering price per Firm Share, and which shall expire five (5) years after the Effective Date. The Underwriter’s Warrant and the Ordinary Shares issuable upon exercise of the Underwriter’s Warrant are hereinafter referred to together as the “Underwriter’s Securities.” The Underwriter understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Underwriter’s Securities during the one hundred eighty (180) days after the Effective Date and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Underwriter’s Securities, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days following the Effective Date to anyone other than (i) an Underwriter or a selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Underwriter or of any such Underwriter or selected dealer; or as otherwise expressly permitted by Rule 5110(e)(2), and only if any such transferee agrees to the foregoing lock-up restrictions.

Warrant Amount; Term. The Company hereby agrees to issue and sell to the Underwriter (and/or its designees) on the Closing Date a warrant for the purchase of a number of the Ordinary Shares equal to 56% of the number of the Firm Shares, issued in the Offering, pursuant to the form attached hereto as Exhibit A (the “Underwriter’s Warrant”), at an initial exercise price of $[●], which is equal to 120% of the public offering price per Firm Share, and which shall expire five (5) years after the Effective Date. The Underwriter’s Warrant and the Ordinary Shares issuable upon exercise of the Underwriter’s Warrant are hereinafter referred to together as the “Underwriter’s Securities.” The Underwriter understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Underwriter’s Securities during the one hundred eighty (180) days after the Effective Date and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Underwriter’s Securities, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days following the Effective Date to anyone other than (i) an Underwriter or a selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Underwriter or of any such Underwriter or selected dealer; or as otherwise expressly permitted by Rule 5110(e)(25110(g), and only if any such transferee agrees to the foregoing lock-up restrictions.

Warrant Amount; Term. The Company hereby agrees to issue and sell to the Underwriter Representative (and/or its designees) on the Closing Date Date, a five-year warrant (the “Representative’s Warrant”) for the purchase of a number 67,500 shares of the Ordinary Shares equal to Common Stock (5% of the number of the Firm Shares, issued in the Offering, ) pursuant to a warrant agreement in the form attached hereto as Exhibit A (the “UnderwriterRepresentative’s WarrantWarrant Agreement”), at an initial exercise price of $[●*], which is equal to 120125% of the public offering price Purchase Price per Firm Share, and which shall expire five (5) years after the Effective Date. The UnderwriterRepresentative’s Warrant and the Ordinary Shares shares of Common Stock issuable upon exercise of the UnderwriterRepresentative’s Warrant are hereinafter referred to together as the “UnderwriterRepresentative’s Securities.” The Underwriter Representative understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the UnderwriterRepresentative’s Securities during Warrant and the one hundred eighty (180) underlying securities within 180 days after the Effective Date and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the UnderwriterRepresentative’s SecuritiesWarrant, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) 180 days following the Effective Date to anyone other than (i) an Underwriter or a selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Underwriter Representative or of any such Underwriter or selected dealer; or as otherwise expressly permitted by Rule 5110(e)(25110(g), and only if any such transferee agrees to the foregoing lock-up restrictions.

Warrant Amount; Term. The Company hereby agrees to issue and sell to the Underwriter Representative (and/or its designees) on the Closing Date or Option Closing Date, as applicable, a five-year warrant for the purchase of a number of the Ordinary Shares shares of Common Stock equal to 510% of the number of the Firm Shares and Option Shares, if any, issued in the Offering, pursuant to a warrant in the form attached hereto as Exhibit A (the “UnderwriterRepresentative’s Warrant”), at an initial exercise price of $[●l], which is equal to 120% of the public offering price per Firm Share, and which shall expire five (5) years after the Effective Date. The UnderwriterRepresentative’s Warrant and the Ordinary Shares shares of Common Stock issuable upon exercise of the UnderwriterRepresentative’s Warrant are hereinafter referred to together as the “UnderwriterRepresentative’s Securities.” The Underwriter Representative understands and agrees that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the UnderwriterRepresentative’s Securities during the one hundred eighty (180) days after the Effective Date and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the UnderwriterRepresentative’s Securities, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred eighty (180) days following the Effective Date to anyone other than (i) an Underwriter or a selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Underwriter Representative or of any such Underwriter or selected dealer; or as otherwise expressly permitted by Rule 5110(e)(25110(g), and only if any such transferee agrees to the foregoing lock-up restrictions.